Rita Cascão

1.5k total citations
39 papers, 1.1k citations indexed

About

Rita Cascão is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Rita Cascão has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Rheumatology and 11 papers in Oncology. Recurrent topics in Rita Cascão's work include Rheumatoid Arthritis Research and Therapies (15 papers), Bone Metabolism and Diseases (9 papers) and Natural Compounds in Disease Treatment (8 papers). Rita Cascão is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Bone Metabolism and Diseases (9 papers) and Natural Compounds in Disease Treatment (8 papers). Rita Cascão collaborates with scholars based in Portugal, United Kingdom and Finland. Rita Cascão's co-authors include João Eurico Fonseca, Luís F. Moita, H.S. Rosário, Margarida Souto‐Carneiro, Bruno Vidal, Helena Canhão, Ana Maria Rodrigues, Helena Raquel, Inês P. Perpétuo and Nuno Figueiredo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rita Cascão

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita Cascão Portugal 16 425 310 279 228 129 39 1.1k
Ernesta Palombo‐Kinne Germany 14 372 0.9× 426 1.4× 350 1.3× 33 0.1× 99 0.8× 20 1.2k
Baihua Shen China 22 671 1.6× 215 0.7× 509 1.8× 103 0.5× 90 0.7× 40 1.4k
Gerd-R. Burmester Germany 7 462 1.1× 413 1.3× 428 1.5× 37 0.2× 163 1.3× 9 1.2k
Xuezhi Yang China 14 308 0.7× 171 0.6× 201 0.7× 49 0.2× 41 0.3× 28 690
Jiajie Tu China 24 846 2.0× 268 0.9× 477 1.7× 71 0.3× 84 0.7× 61 1.8k
Roxana Coras United States 13 398 0.9× 567 1.8× 150 0.5× 29 0.1× 43 0.3× 26 1.0k
Se Hwan Mun South Korea 22 964 2.3× 283 0.9× 496 1.8× 38 0.2× 78 0.6× 51 1.7k
Christelle Boileau Canada 21 511 1.2× 897 2.9× 147 0.5× 33 0.1× 77 0.6× 28 1.5k
Haiyan Zhang China 19 505 1.2× 463 1.5× 183 0.7× 44 0.2× 30 0.2× 50 1.1k
Chuangxin Lin China 14 449 1.1× 426 1.4× 180 0.6× 28 0.1× 31 0.2× 23 1.1k

Countries citing papers authored by Rita Cascão

Since Specialization
Citations

This map shows the geographic impact of Rita Cascão's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Cascão with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Cascão more than expected).

Fields of papers citing papers by Rita Cascão

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Cascão. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Cascão. The network helps show where Rita Cascão may publish in the future.

Co-authorship network of co-authors of Rita Cascão

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Cascão. A scholar is included among the top collaborators of Rita Cascão based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Cascão. Rita Cascão is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muyas, Francesc, Manuel J. Gómez, Rita Cascão, et al.. (2024). The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients. Nature Communications. 15(1). 82–82. 4 indexed citations
2.
Vidal, Bruno, et al.. (2024). Effects of Ab501 (certolizumab mice equivalent) in arthritis induced bone loss. PubMed. 3(4). 268–276. 1 indexed citations
3.
Cascão, Rita, et al.. (2023). Role of UBE2C in Brain Cancer Invasion and Dissemination. International Journal of Molecular Sciences. 24(21). 15792–15792. 10 indexed citations
4.
Ferreira, Hugo Alexandre, et al.. (2023). Nanoparticle-Based Treatment in Glioblastoma. Journal of Personalized Medicine. 13(9). 1328–1328. 23 indexed citations
5.
Faria, Cláudia C., et al.. (2023). Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma. Pharmaceutics. 15(3). 928–928. 15 indexed citations
6.
Cascão, Rita, Carlos Custódia, Nan Qin, et al.. (2023). UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease. Neuro-Oncology Advances. 5(1). vdad048–vdad048. 3 indexed citations
7.
Faria, Cláudia C., Rita Cascão, Carlos Custódia, et al.. (2022). Patient-derived models of brain metastases recapitulate human disseminated disease. Cell Reports Medicine. 3(5). 100623–100623. 10 indexed citations
8.
Cascão, Rita, Bruno Vidal, Tânia Carvalho, et al.. (2020). Celastrol Efficacy by Oral Administration in the Adjuvant-Induced Arthritis Model. Frontiers in Medicine. 7. 455–455. 16 indexed citations
9.
Vidal, Bruno, Rita Cascão, Mikko Finnilä, et al.. (2018). Early arthritis induces disturbances at bone nanostructural level reflected in decreased tissue hardness in an animal model of arthritis. PLoS ONE. 13(1). e0190920–e0190920. 8 indexed citations
10.
Vidal, Bruno, Rita Cascão, Mikko Finnilä, et al.. (2017). AB0098 Effects of tofacitinib in early arthritis bone loss. Annals of the Rheumatic Diseases. 76. 1080–1080. 4 indexed citations
11.
Cascão, Rita, João Eurico Fonseca, & Luís F. Moita. (2017). Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases. Frontiers in Medicine. 4. 69–69. 195 indexed citations
12.
Vidal, Bruno, Rita Cascão, Ana C. Vale, et al.. (2015). Arthritis Induces Early Bone High Turnover, Structural Degradation and Mechanical Weakness. PLoS ONE. 10(1). e0117100–e0117100. 12 indexed citations
13.
Cascão, Rita, et al.. (2015). Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats. PLoS ONE. 10(12). e0142448–e0142448. 29 indexed citations
14.
Cascão, Rita, Bruno Vidal, Helena Raquel, et al.. (2014). Potent Anti-Inflammatory and Antiproliferative Effects of Gambogic Acid in a Rat Model of Antigen-Induced Arthritis. Mediators of Inflammation. 2014. 1–7. 28 indexed citations
15.
Cascão, Rita, Bruno Vidal, Helena Raquel, et al.. (2012). Effective treatment of rat adjuvant-induced arthritis by celastrol. Autoimmunity Reviews. 11(12). 856–862. 104 indexed citations
16.
Moura, R. A., Rita Cascão, Inês P. Perpétuo, et al.. (2011). Spondyloarthritis and rheumatoid arthritis: different clinical manifestations, similar cytokine network. Annals of the Rheumatic Diseases. 70. A82–A83. 2 indexed citations
17.
Cascão, Rita, R. A. Moura, Inês P. Perpétuo, et al.. (2010). Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Research & Therapy. 12(5). R196–R196. 96 indexed citations
18.
Cascão, Rita, H.S. Rosário, Margarida Souto‐Carneiro, & João Eurico Fonseca. (2010). Neutrophils in rheumatoid arthritis: More than simple final effectors. Autoimmunity Reviews. 9(8). 531–535. 186 indexed citations
19.
Caetano‐Lopes, Joana, Helena Canhão, Joana Duarte, et al.. (2010). Chronic arthritis leads to disturbances in the bone collagen network. Arthritis Research & Therapy. 12(1). R9–R9. 28 indexed citations
20.
Moura, R. A., Rita Cascão, Inês P. Perpétuo, et al.. (2010). Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. Lara D. Veeken. 50(2). 278–282. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026